002901.SZ SHZ
Double Medical Technology Inc.
1W: +0.7%
1M: -2.4%
3M: -5.0%
YTD: -16.0%
1Y: -30.4%
3Y: +35.9%
5Y: -35.1%
¥40.86 ($6.09)
+0.30 (+0.74%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Income Trends
Revenue
$2.1B
+39.3% ▲
5Y CAGR: +11.2%
Gross Profit
$1.4B
+43.7% ▲
5Y CAGR: +5.8%
Operating Income
$430M
+316.2% ▲
5Y CAGR: -5.5%
Net Income
$357M
+505.2% ▲
5Y CAGR: -5.2%
EPS (Diluted)
$0.86
+514.3% ▲
5Y CAGR: -5.8%
EBITDA
$447M
+268.4% ▲
5Y CAGR: -3.3%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $1.6B | $2.0B | $1.4B | $1.5B | $2.1B |
| YoY Growth | +26.2% | +25.7% | -28.1% | +6.9% | +39.3% |
| Cost of Revenue | $231M | $319M | $345M | $542M | $710M |
| Gross Profit | $1.4B | $1.7B | $1.1B | $992M | $1.4B |
| Gross Margin | 85.5% | 84.0% | 76.0% | 64.7% | 66.7% |
| R&D Expenses | $128M | $167M | $257M | $285M | $307M |
| SG&A Expenses | $565M | $747M | $788M | $691M | $769M |
| Operating Expenses | $641M | $853M | $942M | $888M | $996M |
| Operating Income | $715M | $822M | $147M | $103M | $430M |
| Operating Margin | 45.0% | 41.2% | 10.3% | 6.7% | 20.1% |
| Interest Expense | $143K | $747K | $3M | $7M | $7M |
| Income Before Tax | $710M | $803M | $147M | $100M | $428M |
| Tax Expense | $95M | $111M | $38M | $13M | $43M |
| Net Income | $606M | $673M | $93M | $59M | $357M |
| Net Margin | 38.2% | 33.8% | 6.5% | 3.8% | 16.7% |
| EPS (Diluted) | $1.51 | $1.67 | $0.22 | $0.14 | $0.86 |
| EBITDA | $683M | $782M | $117M | $121M | $447M |
| Shares Outstanding | 400M | 403M | 414M | 421M | 415M |